This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Safety and Efficacy of LEE011 and LGX818 in Patien...
Clinical trial

Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma.

Read time: 1 mins
Last updated:22nd Jan 2013
To evaluate the safety, tolerability and efficacy of LEE011 and LGX818 when administered orally to patients with BRAF mutant melanoma.
Category Value
Study start date 2013-01-22

View full details